Stock HSTC HST GLOBAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials HST Global, Inc.

Equities

HSTC

US40432E2028

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 18:38:27 06/05/2024 BST 		5-day change 1st Jan Change
1.1 USD 0.00% Intraday chart for HST Global, Inc. 0.00% +81.07%
04-05 HST Global, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 HST Global, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 0.202 0.5098 0.3059 0.5773 0.6298 3.189
Enterprise Value (EV) 1 1.577 0.5078 0.3309 0.6322 0.7057 3.285
P/E ratio -1.13 x 0.92 x -1.64 x -3.89 x -4.34 x -21.8 x
Yield - - - - - -
Capitalization / Revenue - - - - - -
EV / Revenue - - - - - -
EV / EBITDA - - - - - -
EV / FCF - - 6,436,929 x 24,504,671 x 21,149,485 x 96,845,975 x
FCF Yield - - 0% 0% 0% 0%
Price to Book -0.06 x -149 x -2.48 x -1.92 x -1.41 x -5.39 x
Nbr of stocks (in thousands) 2,448 4,248 4,248 5,249 5,249 5,249
Reference price 2 0.0825 0.1200 0.0720 0.1100 0.1200 0.6075
Announcement Date 02/04/19 09/04/20 14/04/21 04/03/22 31/01/23 05/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales - - - - - -
EBITDA - - - - - -
EBIT 1 -0.1426 -0.1516 -0.208 -0.1457 -0.141 -0.1409
Operating Margin - - - - - -
Earnings before Tax (EBT) 1 -0.1783 0.4266 -0.209 -0.1484 -0.1451 -0.1462
Net income 1 -0.1783 0.4266 -0.209 -0.1484 -0.1451 -0.1462
Net margin - - - - - -
EPS 2 -0.0728 0.1305 -0.0438 -0.0283 -0.0276 -0.0279
Free Cash Flow - - 0.0514 0.0258 0.0334 0.0339
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 02/04/19 09/04/20 14/04/21 04/03/22 31/01/23 05/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 1.38 - 0.03 0.05 0.08 0.1
Net Cash position 1 - 0 - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - 0.05 0.03 0.03 0.03
ROE (net income / shareholders' equity) 5.43% -25.3% 268% 65.5% 38.9% 28.2%
ROA (Net income/ Total Assets) - - -9,945% -20,605% -42,583% -10,264%
Assets 1 - - 0.002101 0.00072 0.000341 0.001424
Book Value Per Share 2 -1.380 -0 -0.0300 -0.0600 -0.0800 -0.1100
Cash Flow per Share - 0 0 0 0 0
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 02/04/19 09/04/20 14/04/21 04/03/22 31/01/23 05/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
HST GLOBAL, INC. Stock HST Global, Inc.
+81.07% 5.77M
MODERNA, INC. Stock Moderna, Inc.
+26.37% 48.16B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.01% 41.73B
LONZA GROUP AG Stock Lonza Group AG
+42.44% 41.03B
CELLTRION, INC. Stock Celltrion, Inc.
-5.31% 28.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+9.34% 25.59B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.69% 18.96B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+6.23% 12.92B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.99% 12.03B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.38% 11.77B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. HSTC Stock
  4. Financials HST Global, Inc.